Trump's head of the Department of Health and Human Services traded stocks of health-related companies while working on legislation affecting the firms.
This article first appeared March 17, 2017 on ProPublica.
Update, Mar. 19, 2017: Asked about this report during an appearance today on ABC News' "This Week with George Stephanopoulos," Health and Human Services Secretary Tom Price said he and his lawyers haven't received any indication of a federal investigation into his stock trades. "I know nothing about that whatsoever," Price said.
Former U.S. Attorney Preet Bharara, who was removed from his post by the Trump administration last week, was overseeing an investigation into stock trades made by the president's health secretary, according to a person familiar with the office.
Tom Price, head of the Department of Health and Human Services, came under scrutiny during his confirmation hearings for investments he made while serving in Congress. The Georgia lawmaker traded hundreds of thousands of dollars worth of shares in health-related companies, even as he voted on and sponsored legislation affecting the industry.
Price testified at the time that his trades were lawful and transparent. Democrats accused him of potentially using his office to enrich himself. One lawmaker called for an investigation by the Securities and Exchange Commission, citing concerns Price could have violated the STOCK Act, a 2012 law signed by President Obama that clarified that members of Congress cannot use nonpublic information for profit and requires them to promptly disclose their trades.
The investigation of Price's trades by the U.S. Attorney's Office for the Southern District of New York, which hasn't been previously disclosed, was underway at the time of Bharara's dismissal, said the person.
ProPublica is an independent, non-profit newsroom that produces investigative journalism in the public interest.